Aviva Reports 2025 Full Year Results and Declares Final Dividend

This language is standard across UK insurers since Solvency II. It keeps flexibility if market conditions or capital levels change. It is worth being aware of, but on its own does not imply anything negative.

Where to find Aviva’s 2025 full-year results and Annual Report

The detailed numbers, strategy and segment performance are in the documents below:

• Full Year Results and Annual Report and Accounts for the year ending 31 December 2025: PDF 1 and PDF 2
• They will also be available on Aviva’s site: www.aviva.com/investors/results-presentations-reports
• Filed at the FCA’s National Storage Mechanism: FCA NSM

Headline P&L numbers, operating profit and cash remittance are not disclosed in this RNS. To understand dividend affordability, look for cash generation, Solvency II metrics and capital return commentary in the full results.

Balance sheet signals: Solvency II surplus and scale

Aviva flags two helpful markers of financial strength as at 31 December 2025:

• Estimated Solvency II shareholder capital surplus: £7.1 billion
• Total Group assets under management at Aviva Group: £454 billion

The Solvency II surplus is the capital above regulatory requirements. A £7.1 billion surplus suggests room to support dividends and absorb shocks, though the actual solvency ratio – surplus as a percentage of the requirement – is not disclosed here.

Scale also matters. With 25.2 million customers and £31.9 billion paid in claims and benefits in 2025, Aviva remains the UK’s only diversified insurer operating across the UK, Ireland and Canada, with international investments in India and China. Diversification can smooth earnings over time – a positive if you rely on the dividend.

Why the 26.2p dividend matters for investors

Income investors will welcome the clarity on a 26.2p final dividend. Your actual yield depends on your share price, so that will vary by holder. What you can bank on today is the company’s intent to keep returning cash, subject to capital and regulatory limits.

For long-term holders, the DRIP offers a way to compound without trading costs. For those preferring cash, the May payment lands ahead of the summer – useful from a personal cash flow angle.

What’s positive, what to watch

• Positives:
  • Clear final dividend of 26.2p with firm payment, record and DRIP dates.
  • Healthy headline capital buffer – £7.1 billion Solvency II shareholder surplus.
  • Scale and diversification across life, pensions and general insurance markets.
• Watchouts:
  • Dividend remains cancellable until 14 May 2026 – a standard regulatory feature, but still a risk.
  • Ex-dividend date not disclosed here – confirm with your broker once published.
  • Key income cover metrics (cash generation, solvency ratio, operating profit) are not in this RNS – read the full results.

Practical next steps for shareholders

• If you want the dividend, ensure you are on the register by the 27 March 2026 record date. The ex-dividend date will determine trading eligibility – not disclosed here.
• Decide cash vs DRIP and submit your election by 22 April 2026 if opting for shares.
• ADR holders should expect payment about four business days after 14 May 2026.
• Once the reports are up, review capital, cash and outlook sections to gauge dividend sustainability.

Quick facts from the RNS

Company	Aviva plc (FTSE 100)
Final dividend	26.2p per Ordinary share
Record date	27 March 2026
Payment date	14 May 2026
DRIP election deadline	22 April 2026
Dividend cancellable?	Yes – directors retain discretion up to payment, per PRA rules
Solvency II shareholder surplus (31 Dec 2025)	£7.1 billion
Assets under management (31 Dec 2025)	£454 billion
Customers	25.2 million
Claims and benefits paid in 2025	£31.9 billion
Geographies	UK, Ireland, Canada; investments in India and China

Final take from Josh

This is a clean, practical update: a 26.2p final dividend with sensible timelines, backed by a hefty Solvency II surplus and the scale you would expect from a FTSE 100 insurer. The standard cancellability clause is there, but the board signals no intention to use it unless required by regulation.

The real story on earnings power will be in the results and Annual Report. For now, income holders have dates to circle and a decision to make on cash vs DRIP. Simple, solid, and worth a look once the full numbers land.